CRBP insider plans sale of 12,000 shares

An affiliate of CRBP has filed notice of intent to sell up to 12,000 shares of common stock through broker Stifel Nicolaus & Company Inc. on or after 08/07/2026 on the Nasdaq market, with an indicated aggregate market value of $120,971.00.

Rhea-AI Filing Summary

An affiliate of CRBP has filed notice of intent to sell up to 12,000 shares of common stock through broker Stifel Nicolaus & Company Inc. on or after 08/07/2026 on the Nasdaq market, with an indicated aggregate market value of $120,971.00.

The shares relate to equity compensation in the form of Restricted Stock Units, including 7,317 shares tied to RSUs dated 02/12/2026 and 4,683 shares tied to RSUs dated 01/31/2026.

Key Figures

Shares to be sold: 12,000 shares Aggregate market value: $120,971.00 Planned sale date: 08/07/2026 +2 more

5 metrics

Shares to be sold 12,000 shares Common stock indicated in Form 144 for potential sale

Aggregate market value $120,971.00 Indicated value of 12,000 common shares to be sold

Planned sale date 08/07/2026 Date associated with the Nasdaq sale of common stock

RSU-related shares (02/12/2026) 7,317 shares Common stock tied to Restricted Stock Units dated 02/12/2026

RSU-related shares (01/31/2026) 4,683 shares Common stock tied to Restricted Stock Units dated 01/31/2026

Key Terms

Form 144, Restricted Stock Units, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities Information Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | | | 7317 | 02/12/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Compensation financial

"02/12/2026 | Equity Compensation Common Stock | 01/31/2026"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for CRBP in this Form 144?

An affiliate of CRBP indicates an intent to sell up to 12,000 shares of common stock through Stifel Nicolaus & Company Inc. on or after 08/07/2026 on the Nasdaq market.

What is the estimated market value of the CRBP shares to be sold?

The notice covers up to 12,000 shares of CRBP common stock with an aggregate market value of $120,971.00, based on the pricing information provided in the Form 144 disclosure.

What is the source of the CRBP shares covered by this Form 144?

The 12,000 shares of CRBP common stock are tied to Restricted Stock Units granted as equity compensation by the issuer, with grants dated 01/31/2026 and 02/12/2026.

How many CRBP RSU-related shares are linked to each grant date?

The Form 144 shows 7,317 shares associated with Restricted Stock Units dated 02/12/2026 and 4,683 shares associated with Restricted Stock Units dated 01/31/2026, totaling 12,000 shares.

Which broker is handling the potential CRBP stock sale?

The common stock sale for up to 12,000 CRBP shares is to be executed through Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:24 PM Accepted by SEC EDGAR 08/07/2026 - 04:23 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972481
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corbus Pharmaceuticals Holdings, Inc.
SEC File Number	001-37348
Address of Issuer	500 RIVER RIDGE DRIVE NORWOOD MASSACHUSETTS 02062
Phone	617-963-0103
Name of Person for Whose Account the Securities are To Be Sold	Stifel, Nicolaus & Company, Inc CIAS /FA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	12000	120971.00	19341293	08/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/12/2026	Restricted Stock Units	Issuer			7317	02/12/2026	Equity Compensation
Common Stock	01/31/2026	Restricted Stock Units	Issuer			4683	01/31/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Azad Daswani, as a duly authorized representative of STIFEL, as attorney-in-fact for Corbus Pharmaceuticals Holding
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)